Classification, Clinicopathological Features, and Prognosis of Thymomas
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Pathology and Molecular Diagnostics".
Deadline for manuscript submissions: closed (31 August 2022) | Viewed by 760
Special Issue Editors
Interests: lung neoplasm; thymic tumors; mediastinum; thoracic cancer treatments; surgery; non-small cell lung cancer; minimally invasive surgery
Special Issues, Collections and Topics in MDPI journals
2. Department of Medicine and Translational Surgery, Catholic University of Rome, 00153 Roma, Italy
Interests: imaging in lung cancer; imaging in pleural and mediastinal tumors; PET CT scan in thoracic neoplasms
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
We are proposing a Special Issue entitled “Classification, Clinicopathological Features, and Prognosis of Thymomas”. Thymic epithelial tumors are considered rare tumors, but knowledge and innovation regarding their biology, diagnosis, and treatment have evolved rapidly, especially in recent decades, with improvements in diagnostic tools and the spectrum of therapies. Moreover, it is now generally accepted that for these tumors, a multidisciplinary approach is mandatory, involving pathologists, (nuclear medicine) radiologists, neurologists, surgeons, and oncologists, and the integration of these figures for thymomas management may lead to a better comprehension of this disease, with important improvements on survival outcome.
For these reasons, we are proposing a specific issue that includes a holistic approach to these tumors, from diagnosis to treatment, with the aim to give complete indications for actual thymoma management, but also looking at perspectives for treatment and long terms outcomes.
Dr. Marco Chiappetta
Prof. Dr. Filippo Lococo
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- thymic epithelial tumor diagnosis
- thymic epithelial tumor staging
- thymic epithelial tumor imaging
- thymic epithelial tumor surgical treatment
- thymic epithelial tumor integrated treatments
